Logo

Vol. 132, No. 7-8

August 21, 2022
On this page
Impact factor 2021 of Polish Archives of Internal Medicine
Anetta Undas
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16305; DOI: 10.20452/pamw.16305
Will sustained biological therapy improve long‑term outcome in inflammatory bowel disease?
Pär Myrelid, Michael Eberhardson
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16309; DOI: 10.20452/pamw.16309
Cardiac biomarkers and prognosis in patients with COVID‑19
Juan R. Rey, Juan Caro-Codón
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16295; DOI: 10.20452/pamw.16295
Biologic treatment of inflammatory bowel disease in Poland, 2012–2020: nationwide data
Piotr Kucha, Edyta Zagórowicz, Dorota Walkiewicz, Jakub Perwieniec, Michał Maluchnik, Paulina Wieszczy, Jarosław Reguła
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16287; DOI: 10.20452/pamw.16287
Cardiac biomarkers on admission and in‑hospital mortality in COVID-19 patients with or without concomitant heart failure
Marek Klocek, Wiktoria Wojciechowska, Michał Terlecki, Christopher Pavlinec, Tomasz Grodzicki, Maciej Małecki, Monika Bociąga-Jasik, Marek Rajzer, and CRACoV-HHS Investigators
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16256; DOI: 10.20452/pamw.16256
Effectiveness of chronic obstructive pulmonary disease (COPD) treatment with a combination of tiotropium / olodaterol in Polish standard clinical practice as measured by the improvement of the Clinical COPD Questionnaire score: an observational study
Aleksander Kania, Natalia Celejewska-Wójcik, Katarzyna Żurowska, Adam Barczyk
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16268; DOI: 10.20452/pamw.16268
The relationship between subclinical depressive symptoms and metabolic parameters in women: a subanalysis of the Bialystok PLUS study
Lidia Łapińska, Zofia Stachurska, Andrzej Raczkowski, Napoleon Waszkiewicz, Karol Kamiński, Irina Kowalska
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16261; DOI: 10.20452/pamw.16261
SARS‑CoV‑2 vaccination in liver transplant recipients: factors affecting immune response and refusal to vaccine
Joanna Raszeja-Wyszomirska, Maciej K. Janik, Maciej Wójcicki, Piotr Milkiewicz
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16274; DOI: 10.20452/pamw.16274
Adherence to prophylactic treatment in adult patients with severe hemophilia in Poland
Joanna Zdziarska, Magdalena Górska-Kosicka, Michał Jamrozik, Justyna Kozińska, Maria Podolak-Dawidziak, Ewa Stefańska-Windyga, Krystyna Zawilska, Krzysztof Chojnowski
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16280; DOI: 10.20452/pamw.16280
Not the enemy: potential protective benefits of superficial subcutaneous adipose tissue
Shou-En Wu, Wei-Liang Chen
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16237; DOI: 10.20452/pamw.16237
How to optimize the prevention of post‑thrombotic syndrome: recent advances
Aaron F. J. Iding, Arina J. ten Cate-Hoek
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16288; DOI: 10.20452/pamw.16288
Molecular cytogenetics in acute myeloid leukemia in adult patients: practical implications
Krzysztof Mrózek
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16300; DOI: 10.20452/pamw.16300
Innovative radioisotope therapy for patients with neuroendocrine tumors using an α (225Ac) emitter labeled somatostatin analog: octreotate. A promising new treatment for advanced progressive neuroendocrine neoplasms
Tadeusz Budlewski, Zbigniew J. Król, Frank Bruchertseifer, Agnieszka Majkowska-Pilip, Alfred Morgenstern, Waldemar Wierzba
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16275; DOI: 10.20452/pamw.16275
Irregular treatment leading to pituitary and scalp involvement in metastatic breast cancer
Chao Hou, Chang-jing Xu, Ming-xing Li, Ji-qing Xuan
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16267; DOI: 10.20452/pamw.16267
Bland‑White‑Garland syndrome in a 35‑year‑old professional soldier: a case report
Sylwia Iwańczyk, Patrycja Woźniak, Aneta Klotzka, Magdalena Janus, Maciej Lesiak, Tatiana Mularek-Kubzdela
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16273; DOI: 10.20452/pamw.16273
SARS‑CoV‑2–induced remission of advanced classical Hodgkin lymphoma
Michał Kurlapski, Grzegorz Romanowicz, Michał Taszner, Jan M. Zaucha
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16266; DOI: 10.20452/pamw.16266
Aortic valve Libman‑Sacks endocarditis mimicking papillary fibroelastoma: therapeutic possibilities
Paweł Czub, Karolina Żbikowska, Adam Arendarczyk, Monika Budnik
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16276; DOI: 10.20452/pamw.16276
Increased endocan expression as a biomarker of endothelial dysfunction in patients with metabolic syndrome
Sylwia Iwańczyk, Anna Smukowska-Gorynia, Patrycja Woźniak, Marek Grygier, Maciej Lesiak, Aleksander Araszkiewicz
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16292; DOI: 10.20452/pamw.16292
Treatment of acute coronary syndromes during the COVID‑19 pandemic: a designated COVID‑19 hospital perspective
Marek Słomczyński, Janusz Rzeźniczak, Dominika Kasprzak, Paweł Bugajski, Andrzej Bolewski, Paweł Burchardt
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16298; DOI: 10.20452/pamw.16298
Changes of lipid profile in subclinical hyperthyroidism and following restoration of euthyroidism
Grzegorz Kamiński, Michał Olejarz, Ewelina Szczepanek-Parulska, Marek Ruchała, Marek Saracyn
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16277; DOI: 10.20452/pamw.16277
A series of Polish patients with congenital fibrinogen disorders: 2 new mutations in fibrinogen gamma chain, Fibrinogen Kostrzyn and Fibrinogen Łódź II
Anna Weronska, Anna Klukowska, Marguerite Neerman-Arbez, Jacek Treliński, Anetta Undas, Ewa Wypasek
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16314; DOI: 10.20452/pamw.16314
Cardiac biomarkers are highly prognostic of in‑hospital mortality in patients with COVID‑19: what is the effect of renin angiotensin system blockers without baseline heart failure on these biomarkers?
Dimitrios Patoulias
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16293; DOI: 10.20452/pamw.16293
Cardiac biomarkers are highly prognostic of in‑hospital mortality in patients with COVID‑19: what is the effect of renin angiotensin system blockers without baseline heart failure on these biomarkers? Authors' reply
Marek Klocek, Michał Terlecki, Wiktoria Wojciechowska, Marek Rajzer, Tomasz Grodzicki
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16294; DOI: 10.20452/pamw.16294
Surviving Sepsis Campaign Guidelines 2021: highlights for the practicing clinician
Simon Oczkowski, Fayez Alshamsi, Emilie Belley-Cote, John E. Centofanti, Morten Hylander Møller, Mark E. Nunnaly, Waleed Alhazzani
Pol Arch Intern Med. 2022, Vol. 132, No. 7-8: 16290; DOI: 10.20452/pamw.16290